Surgical Innovations reports trading “in line with market expectations”

A COMPANY which designs and manufactures devices for use in minimally invasive surgery said it traded in line with market expectations last year.
By The Newsroom
Published 23rd Jan 2012, 08:32 BST

Leeds-based Surgical Innovations Group said it continued to trade according to plan in the second half of 2011, with a strong fourth quarter.

In the trading update, published today, the firm said: “The focus towards development of US opportunities is a major element of the company’s strategy, particularly with the current challenges throughout the European market.”

It said orders from the US have continued to grow.

Hide Ad
Hide Ad

The group said it had continued to see “positive results” from its investment program in product development. It said sales of its PretzelFlex laparoscopic retractor have been “encouraging” following its launch in November.

Mike Thornton, formerly a partner at PricewaterhouseCoopers, was appointed as financial director of Surgical Innovations in December.

Graham Bowland, chief executive officer, said: “SI has made progress in 2011, particularly in the US and in the development and launch of new products. The group looks forward with confidence.”

Preliminary results for the year to December 31, 2011, are expected to be released on April 24.

Related topics:LeedsPricewaterhouseCoopers